Bullish Case: DKNG sits at $21.8 with calls outpacing puts 63% and bullish risk 4% above bearish across tenors. CEO Robins publicly dismisses prediction-market cannibalization, NFL handle is growing ~15% MoM, prediction volumes have tripled since July, and the Nov 21 earnings window (IV 62% vs ~52% October) prices in a re-rating catalyst. The $12/18 25C (4,259 vol) shows real upside positioning.

Bearish Case: Shares fell 16% in a month and 10% in a week to $21.8. The NYT AI-targeting scandal plus SAFE Bet Act proposals create fresh regulatory/ethical overhang; $3B promotional spend and thinning margins compress estimates; the Cantor/Lutnick patent fight adds legal cost; term structure shows near-term IV ~62-84% with downside-heavy density below $25 (market PDF peaks at $24.5-25).

Potential Outcomes:

1. 40% Chop $20-24 into November earnings — Helium density mode ~$24-24.5, forecast -1.81%.
2. 22% Rebound $25-28 if NFL handle beats and AI/regulatory noise fades — falsifiable: closes >$24 with call skew persistence.
3. 20% Slide $17-20 on AI-predatory headlines, SAFE Bet Act momentum, or margin cuts — falsifiable: low-strike put IV (17.5-20) widening.
4. 10% Rally $28-31 on strong Q3 print Nov 6-7 window.
5. 8% Regulatory/litigation crash <$16.

September 23, 2026